GH RESEARCH PLC news, videos and press releases
For more news please use our advanced search feature.
GH RESEARCH PLC - More news...
GH RESEARCH PLC - More news...
- GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
- GH Research Announces Pricing of $150 Million Public Offering
- GH Research Announces Proposed Public Offering
- GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
- GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
- GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
- GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
- GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
- GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
- GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
- GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
- GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
- GH Research Reports Third Quarter Financial Results and Provides Business Updates
- GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
- GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
- GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
- GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
- GH Research Provides Business Updates and Highlights Key Upcoming Milestones
- GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
- GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates
- GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates
- GH Research Reports Full Year 2021 Financial Results and Provides Business Updates
- GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates
- GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression
- GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results
